SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-012922
Filing Date
2024-09-20
Accepted
2024-09-20 16:15:12
Documents
14
Period of Report
2024-09-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K elev-20240918x8k.htm   iXBRL 8-K 34755
  Complete submission text file 0001558370-24-012922.txt   167423

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20240918.xsd EX-101.SCH 3964
3 EX-101.DEF elev-20240918_def.xml EX-101.DEF 2820
4 EX-101.LAB elev-20240918_lab.xml EX-101.LAB 17916
5 EX-101.PRE elev-20240918_pre.xml EX-101.PRE 11884
16 EXTRACTED XBRL INSTANCE DOCUMENT elev-20240918x8k_htm.xml XML 5046
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 241313549
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)